Agilent Technologies and PULSION Medical Systems Introduce Hemodynamic Assessment Tool to U.S. Market.Business Editors & Health/Medical Writers BIOWIRE2K PALO ALTO, Calif. and MUNICH, Germany--(BW HealthWire)--May 21, 2001 Agilent Technologies Inc. (NYSE NYSE See: New York Stock Exchange :A) and PULSION Medical Systems AG of Munich, Germany, today announced the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. 510(K) clearance and the U.S. introduction of a jointly developed hemodynamic he·mo·dy·nam·ics n. (used with a sing. verb) The study of the forces involved in the circulation of blood. he assessment tool based on PULSION's established PiCCO technology. As part of a global alliance, Agilent Technologies and PULSION Medical Systems have agreed to market a continuous cardiac output cardiac output n. Abbr. CO The volume of blood pumped from the right or left ventricle in one minute. It is equal to the stroke volume multiplied by the heart rate. measurement technology, which is integrated into the latest release of the Agilent CMS (1) See content management system and color management system. (2) (Conversational Monitor System) Software that provides interactive communications for IBM's VM operating system. 2001 acute care patient monitors. This continuous approach to hemodynamic monitoring introduces a new method for cardiac status and vascular volume monitoring, making these measurements available to a wider patient population, including small children. Because PiCCO requires only a central venous and an arterial catheter, the method avoids complications associated with right heart catheterization right heart catheterization Pulmonary artery catheterization Cardiology A technique for direct measurement of cardiac function, consisting of the introduction of a catheter into the right atrium, right ventricle, pulmonary artery Data Hemodynamic measurements, . The PiCCO method delivers information on cardiac output as well as hemodynamic parameters such as intrathoracic blood volume, which enables the user to guide fluid therapy. "The integration of PiCCO technology into Agilent CMS patient monitors offers clinicians easy access to continuous cardiac output (CCO (Chief or Corporate Compliance Officer) The executive person in charge of compliance issues, regulatory requirements, internal controls and managing audits within an enterprise or organization. ) and other advanced hemodynamic parameters, such as intrathoracic blood volume, to guide fluid therapy. Clinicians can also access CCO values via the Agilent Information Center at the nurse's central," said David Russell, marketing manager of Agilent's Patient Monitoring Division. "This new hemodynamic assessment tool underlines our continued commitment to provide innovative and effective new measurement technologies to our customers." The PiCCO method combines easy setup -- with robust and reliable results -- and ease of interpretation into a system that compares favorably with traditional methods of determining cardiac output. For ventilated ven·ti·late tr.v. ven·ti·lat·ed, ven·ti·lat·ing, ven·ti·lates 1. To admit fresh air into (a mine, for example) to replace stale or noxious air. 2. patients, the cardiac preload preload /pre·load/ (pre´lod) the mechanical state of the heart at the end of diastole, the magnitude of the maximal (end-diastolic) ventricular volume or the end-diastolic pressure stretching the ventricles. information is independent of the ventilator settings and respiratory cycle. The small catheter size makes hemodynamic monitoring possible on children as small as 4.4 lb. (2 kg). "Obtaining FDA approval for the incorporation of the PiCCO technology into Agilent's CMS patient monitors is a significant advancement in enabling comprehensive patient management at the bedside. With Agilent's continuous cardiac output module for Agilent CMS customers and our standalone PiCCO monitor, the PiCCO method is now available in every major market around the globe. In conjunction with our own subsidiary in the United States, we are now able to promote our innovative technology within the world's largest medical device market," said Dr. Ulrich J Pfeiffer, MD, Ph.D., PULSION's CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. and founder. About PULSION Medical Systems PULSION Medical Systems AG, Munich, Germany, is a life science company with medical devices for diagnosis and therapy. PULSION Medical Systems is a technology leader in less invasive physiological monitoring. The company holds a unique position in the market niche between medical device technology and the pharmaceutical industry. With 100 employees, PULSION Medical Systems successfully develops, manufactures and markets products within both these arenas; providing a comprehensive package of devices and disposals and ICG ICG indocyanine green. PULSION, which is an approved drug. PULSION Medical Systems consistently sets new standards in medical technology and has successfully expanded to include six international distribution subsidiaries. With a global strategic alliance with Agilent Technologies, and a complement of extensive product lines, the profile of PULSION Medical Systems will continue to expand in the future. PULSION Medical Systems can be found on the Web at www.pulsionmedical.com/. About Agilent Technologies Agilent Technologies Inc. (NYSE:A) is a global technology leader in communications, electronics, life sciences and healthcare. With 48,000 employees serving customers in more than 120 countries, Agilent had net revenue of $10.8 billion in fiscal year 2000. Information about Agilent can be found on the Web at www.agilent.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion